ESET Research uncovers variants of AsyncRAT, popular choice of cybercriminals
HERE Technologies Launches GIS Data Suite: A New Standard in Foundational GIS Data for Esri Users
Akka Introduces Agentic AI Platform
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi’s Desert Dragons facilities
KIN-2787 is the company’s RAF inhibitor candidate for patients with mutant BRAF-driven solid tumors Planned…
FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to…
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., May 17, 2021…
The National Institute of Allergy and Infectious Diseases will fund the continued clinical development of…
CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
NEWTON, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Advancing two lead product candidates in Phase 1/2 clinical trials Completed successful $126M initial public…
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase…
Advicenne reçoit un avis positif de la FDA sur la procédure d’approbation et l’Agence accepte…
Company announcement no. 16 – 2117 May 2021 NTG Nordic Transport Group publishes interim report…
Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of…
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 17 May 2021 – On 7…
UPPSALA, SWEDEN – LIDDS Annual General Meeting (AGM) was held on May 17, 2021….
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks…
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Multi-center Retrospective Study Demonstrates Statistically Significant Reduction in Signs and Symptoms of Dry Eye Disease…
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS17 MAY 2021 at 16.00 EEST …
THCVHS combined with netarsudil (Rhopressa®) achieves an average maximum intraocular pressure (IOP) reduction of…